Aarti Industries Ltd
Aarti Industries Ltd
ChemicalsKey Fundamentals
SmallcapSpecialty ChemicalsChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Aarti Industries Ltd insights
49 extracted metrics + investor summaries across FY11–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
6- Stock is trading at 3.25 times its book value
- Tax rate seems low
- Company has a low return on equity of 7.11% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 9.43% of profits over last 3 years
- Debtor days have increased from 50.1 to 61.8 days.
Growth Rate
AI Analysis — Bull vs Bear
Aarti Industries trades at a market cap of ₹18,973 Cr with a PE of 36.7x and a 3-year ROE of just 7%. The company has shown a sharp TTM profit recovery of 122% and TTM sales growth of 27%, but longer-term profit compounding remains negative at -9% over 3 years and -5% over 5 years.
- TTM profit growth of 122% signals a strong cyclical recovery in earnings after a multi-year downturn
- TTM sales growth of 27% indicates improving demand and pricing environment for specialty chemicals
- 10-year compounded sales growth of 11% demonstrates consistent long-term revenue scaling ability
- Stock CAGR of 43% over the last 1 year reflects renewed market confidence in the business turnaround
- 10-year stock CAGR of 15% shows the company has delivered meaningful long-term wealth creation
- 5-year compounded sales growth of 13% is healthy and ahead of many chemical peers
- 10-year ROE averaging 14% suggests the business has historically been capable of generating superior returns on equity
- 3-year compounded profit growth is -9%, indicating earnings destruction over the medium term despite revenue growth
- 3-year ROE of only 7% is well below cost of equity and reflects poor capital efficiency in recent years
- PE of 36.7x is elevated relative to the 7% ROE, suggesting the stock is priced for a recovery that must materialize
- Price-to-book of 3.28x is high given the subdued return ratios, limiting margin of safety
- Debtor days have increased from 50.1 to 61.8 days, signalling deteriorating working capital discipline
- Dividend payout of only 9.43% of profits over 3 years offers negligible income to shareholders
- 5-year compounded profit growth of -5% shows earnings have not kept pace even with 13% sales CAGR, pointing to margin pressure
- Potential interest cost capitalization, if confirmed, would mean reported profits overstate true economic earnings
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Q1FY27 net profit jumps 227% Jul 30
Standalone net profit rose 227% YoY to ₹144 crore in Q1FY27, driven by higher revenue and improved margins. Consolidated PAT surged 260% YoY to ₹155 crore.
- New China subsidiary approved Jul 30
Board approved incorporation of a wholly owned subsidiary in China on July 30, 2026, citing strategic expansion into the market.
- Suyog Kotecha appointed as MD Jul 30
CEO Suyog Kotecha appointed Managing Director effective October 1, 2026, while three Gogri promoter directors transition to Non-Executive roles, signalling professional management.
- Investor meetings in Asia Aug 6
Management to attend investor meetings in Singapore and Hong Kong from August 11-14, 2026, with analysts from Nuvama and Avendus.
- Promoter stake reclassified Jul 30
Board approved moving Ratanben Premji Gogri (0.38% stake) from Promoter Group to Public category, pending exchange approval.
- Q1FY27 earnings call hosted Jul 31
Audio recording of Q1FY27 earnings call uploaded to website per SEBI LODR Regulation 30. Call held on July 31, 2026.
TL;DR: Aarti Industries delivered a strong Q1FY27 with profit growth of 227% YoY, indicating a sharp earnings recovery. Strategic moves include a China subsidiary and transition to professional management under a new MD. No notable headwinds emerged in the recent newsflow. The trend is clearly improving, and sustained margin expansion in coming quarters will be key to watch.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,414 | 1,454 | 1,732 | 1,773 | 1,851 | 1,628 | 1,843 | 1,949 | 1,675 | 2,100 | 2,318 | 2,205 | 2,387 |
| Expenses | 1,214 | 1,221 | 1,473 | 1,489 | 1,546 | 1,431 | 1,612 | 1,687 | 1,463 | 1,809 | 1,997 | 1,864 | 2,005 |
| Operating Profit | 200 | 233 | 259 | 284 | 305 | 197 | 231 | 262 | 212 | 291 | 321 | 341 | 382 |
| OPM % | 14% | 16% | 15% | 16% | 16% | 12% | 13% | 13% | 13% | 14% | 14% | 15% | 16% |
| Other Income | 0 | 0 | 8 | -1 | 6 | 7 | 5 | 3 | 4 | 22 | -13 | 1 | 5 |
| Interest | 40 | 58 | 54 | 59 | 64 | 62 | 85 | 64 | 60 | 100 | 69 | 112 | 83 |
| Depreciation | 89 | 93 | 97 | 98 | 102 | 108 | 111 | 113 | 114 | 120 | 121 | 119 | 124 |
| PBT | 71 | 82 | 116 | 126 | 145 | 34 | 40 | 88 | 42 | 93 | 118 | 111 | 180 |
| Tax % | 1% | -11% | -7% | -5% | 6% | -53% | -15% | -9% | -2% | -14% | -13% | -23% | 14% |
| Net Profit | 70 | 91 | 124 | 132 | 137 | 52 | 46 | 96 | 43 | 106 | 133 | 137 | 155 |
| EPS in Rs | 1.93 | 2.51 | 3.42 | 3.64 | 3.78 | 1.43 | 1.27 | 2.65 | 1.19 | 2.92 | 3.67 | 3.78 | 4.27 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,890 | 3,006 | 3,163 | 3,806 | 4,168 | 4,186 | 4,506 | 6,086 | 6,619 | 6,371 | 7,271 | 8,286 | 9,010 |
| Expenses | 2,424 | 2,434 | 2,509 | 3,106 | 3,202 | 3,209 | 3,525 | 4,365 | 5,530 | 5,393 | 6,271 | 7,119 | 7,675 |
| Operating Profit | 466 | 572 | 654 | 700 | 965 | 977 | 982 | 1,720 | 1,089 | 978 | 1,000 | 1,167 | 1,335 |
| OPM % | 16% | 19% | 21% | 18% | 23% | 23% | 22% | 28% | 16% | 15% | 14% | 14% | 15% |
| Other Income | 9 | 6 | 2 | 7 | 2 | 9 | 1 | 1 | 1 | 7 | 16 | 12 | 15 |
| Interest | 138 | 117 | 117 | 132 | 183 | 125 | 86 | 102 | 168 | 211 | 275 | 340 | 364 |
| Depreciation | 82 | 98 | 123 | 146 | 163 | 185 | 231 | 246 | 310 | 378 | 434 | 474 | 484 |
| PBT | 255 | 363 | 416 | 429 | 622 | 676 | 665 | 1,372 | 611 | 395 | 307 | 365 | 502 |
| Tax % | 24% | 26% | 21% | 19% | 19% | 19% | 19% | 14% | 11% | -5% | -8% | -15% | — |
| Net Profit | 208 | 268 | 328 | 346 | 504 | 547 | 535 | 1,186 | 545 | 416 | 331 | 419 | 531 |
| EPS in Rs | 5.81 | 7.71 | 9.62 | 10.24 | 14.18 | 15.39 | 15.02 | 32.71 | 15.04 | 11.49 | 9.13 | 11.56 | 14.64 |
| Div. Payout % | 24% | 28% | 3% | 2% | 19% | 11% | 10% | 11% | 17% | 9% | 11% | 9% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 44 | 42 | 41 | 41 | 43 | 87 | 87 | 181 | 181 | 181 | 181 | 181 |
| Reserves | 972 | 1,096 | 1,321 | 1,538 | 2,587 | 2,892 | 3,416 | 4,335 | 4,739 | 5,109 | 5,424 | 5,774 |
| Borrowings | 1,202 | 1,292 | 1,564 | 2,083 | 2,401 | 2,098 | 2,857 | 2,587 | 2,907 | 3,623 | 3,848 | 4,966 |
| Other Liabilities | 719 | 538 | 573 | 730 | 826 | 1,256 | 1,282 | 748 | 754 | 1,203 | 1,661 | 2,378 |
| Total Liabilities | 2,938 | 2,966 | 3,499 | 4,391 | 5,858 | 6,332 | 7,642 | 7,851 | 8,581 | 10,115 | 11,114 | 13,299 |
| Fixed Assets | 967 | 1,246 | 1,697 | 1,998 | 2,147 | 2,468 | 3,593 | 3,595 | 4,861 | 5,649 | 6,377 | 6,556 |
| CWIP | 193 | 313 | 270 | 436 | 795 | 1,418 | 1,298 | 1,346 | 1,096 | 1,229 | 1,454 | 2,030 |
| Investments | 139 | 41 | 47 | 47 | 33 | 37 | 64 | 28 | 17 | 23 | 48 | 132 |
| Other Assets | 1,639 | 1,366 | 1,486 | 1,910 | 2,884 | 2,409 | 2,688 | 2,882 | 2,607 | 3,214 | 3,235 | 4,581 |
| Total Assets | 2,938 | 2,966 | 3,499 | 4,391 | 5,858 | 6,332 | 7,642 | 7,851 | 8,581 | 10,115 | 11,114 | 13,299 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 340 | 574 | 470 | 335 | 736 | 1,102 | 873 | 519 | 1,319 | 1,210 | 1,242 | 775 |
| Investing | -298 | -452 | -529 | -610 | -797 | -1,124 | -1,322 | -1,169 | -1,330 | -1,369 | -1,398 | -1,141 |
| Financing | -23 | -128 | 58 | 279 | 833 | -535 | 614 | 412 | 38 | 420 | -73 | 745 |
| Net Cash Flow | 19 | -7 | 0 | 4 | 772 | -557 | 165 | -239 | 27 | 261 | -229 | 379 |
| Free Cash Flow | 45 | 124 | -60 | -279 | -55 | -23 | -442 | -646 | -8 | -96 | -137 | -346 |
| CFO/OP | 85 | 117 | 87 | 62 | 90 | 130 | 99 | 44 | 129 | 132 | 123 | 67 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55 | 64 | 61 | 63 | 68 | 66 | 64 | 65 | 52 | 49 | 39 | 62 |
| Inventory Days | 123 | 108 | 136 | 144 | 152 | 174 | 190 | 143 | 115 | 121 | 126 | 118 |
| Days Payable | 55 | 67 | 71 | 69 | 55 | 72 | 117 | 53 | 24 | 76 | 107 | 126 |
| Cash Conversion Cycle | 123 | 105 | 125 | 138 | 165 | 168 | 137 | 155 | 143 | 94 | 58 | 54 |
| Working Capital Days | 10 | 10 | -4 | 6 | -14 | -14 | -36 | 22 | -29 | -36 | -44 | -64 |
| ROCE % | 19% | 20% | 19% | 16% | 18% | 15% | 13% | 22% | 10% | 7% | 6% | 7% |
Documents
Frequently Asked Questions about Aarti Industries Ltd
What does Aarti Industries Ltd do?
Where is Aarti Industries Ltd (AARTIIND) listed?
Which sector does Aarti Industries Ltd belong to?
What is the market capitalisation of Aarti Industries Ltd?
What is the PE ratio of Aarti Industries Ltd?
What is the 52-week high and low of Aarti Industries Ltd?
Does Aarti Industries Ltd pay dividends?
What is the Return on Equity (ROE) of Aarti Industries Ltd?
How can I research Aarti Industries Ltd on Tapetide?
Company Information
Aarti Industries Ltd, the flagship company of the Aarti group, manufacturing organic and inorganic chemicals at its major facilities in Vapi, Jhagadia, Dahej and Kutch, in Gujarat and in Tarapur in Maharashtra. The company has a strong market position in the NCB-based specialty chemicals segment.[1]